Literature DB >> 8133099

Bacterial killing by neutrophils in hypertonic environments.

M B Hampton1, S T Chambers, M C Vissers, C C Winterbourn.   

Abstract

The effects of hypertonic sodium chloride and urea solutions on the phagocytosis and killing of Escherichia coli by neutrophils were examined. Neutrophil function was progressively inhibited by increasing osmolarity, with sodium chloride more inhibitory than urea. However, neutrophils killed at 25% of normal rates in 500 mosmol/L NaCl, and in 300 mosmol/L NaCl with 800 mosmol/L urea. These concentrations would rarely be exceeded in the human urinary tract. Inhibition of neutrophil superoxide production and degranulation was similar to that observed with phagocytosis and killing. Neutrophils also phagocytosed and killed E. coli in isotonic and hypertonic urine, but no improvement in function attributable to the uptake of urinary osmoprotectants was evident. It is concluded that physiologic levels of sodium chloride and urea will slow, but not prevent, neutrophil activity at a hypertonic site of infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8133099     DOI: 10.1093/infdis/169.4.839

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Inhibition of Neutrophils by Hypertonic Saline Involves Pannexin-1, CD39, CD73, and Other Ectonucleotidases.

Authors:  Yu Chen; Yi Bao; Jingping Zhang; Tobias Woehrle; Yuka Sumi; Stephan Ledderose; Xiaoou Li; Carola Ledderose; Wolfgang G Junger
Journal:  Shock       Date:  2015-09       Impact factor: 3.454

2.  Hypertonic saline resuscitation of hemorrhagic shock diminishes neutrophil rolling and adherence to endothelium and reduces in vivo vascular leakage.

Authors:  José L Pascual; Lorenzo E Ferri; Andrew J E Seely; Giuseppina Campisi; Prosanto Chaudhury; Betty Giannias; David C Evans; Tarek Razek; René P Michel; Nicolas V Christou
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

3.  Pulmonary contusion primes systemic innate immunity responses.

Authors:  J Jason Hoth; R S Martin; Barbara K Yoza; Jonathan D Wells; J W Meredith; Charles E McCall
Journal:  J Trauma       Date:  2009-07

Review 4.  Hypertonic Solution in Severe COVID-19 Patient: A Potential Adjuvant Therapy.

Authors:  Matheus Gennari-Felipe; Leandro Borges; Alexandre Dermargos; Eleine Weimann; Rui Curi; Tania Cristina Pithon-Curi; Elaine Hatanaka
Journal:  Front Med (Lausanne)       Date:  2022-06-21

5.  Hypertonic saline enhances host response to bacterial challenge by augmenting receptor-independent neutrophil intracellular superoxide formation.

Authors:  Conor J Shields; Adrian W O'Sullivan; Jiang H Wang; Desmond C Winter; William O Kirwan; H Paul Redmond
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

Review 6.  Inhaled hypertonic saline for cystic fibrosis: Reviewing the potential evidence for modulation of neutrophil signalling and function.

Authors:  Emer P Reeves; Cormac McCarthy; Oliver J McElvaney; Maya Sakthi N Vijayan; Michelle M White; Danielle M Dunlea; Kerstin Pohl; Noreen Lacey; Noel G McElvaney
Journal:  World J Crit Care Med       Date:  2015-08-04

7.  Hypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38.

Authors:  W G Junger; D B Hoyt; R E Davis; C Herdon-Remelius; S Namiki; H Junger; W Loomis; A Altman
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

8.  Hypertonic cardiopulmonary bypass primes and endothelial damage.

Authors:  Michael Poullis; Richard Warwick; Priya Sastry; Eustace Fontaine
Journal:  J Extra Corpor Technol       Date:  2008-12

9.  Effects of hypertonic saline on macrophage migration inhibitory factor in traumatic conditions.

Authors:  Jung-Youn Kim; Sung-Hyuk Choi; Young-Hoon Yoon; Sung-Woo Moon; Young-Duck Cho
Journal:  Exp Ther Med       Date:  2012-06-11       Impact factor: 2.447

Review 10.  Operating room use of hypertonic solutions: a clinical review.

Authors:  Gustavo Azoubel; Bartolomeu Nascimento; Mauricio Ferri; Sandro Rizoli
Journal:  Clinics (Sao Paulo)       Date:  2008-12       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.